Clinical and Experimental Medicine

Papers
(The TQCC of Clinical and Experimental Medicine is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Organ-specific manifestations of COVID-19 infection332
Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature224
Emerging treatment strategies for COVID-19 infection216
Sjögren’s syndrome: a systemic autoimmune disease120
Anemia in patients with Covid-19: pathogenesis and clinical significance70
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options54
Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis43
The current state of MiRNAs as biomarkers and therapeutic tools43
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis40
Kidney disease and COVID-19 disease severity—systematic review and meta-analysis39
A review of prognostic and predictive biomarkers in breast cancer33
Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance28
COVID-19: time to flatten the infodemic curve25
Zinc as a complementary treatment for cancer patients: a systematic review24
Expression of BAFF and BAFF receptors in primary Sjögren’s syndrome patients with ectopic germinal center-like structures24
Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer22
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart21
The use of ketogenic diets in cancer patients: a systematic review21
The risk of cardiovascular complications in inflammatory bowel disease19
Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer19
Stem cells therapy in acute myocardial infarction: a new era?16
Immune-inflammatory, coagulation, adhesion, and imaging biomarkers combined in machine learning models improve the prediction of death 1 year after ischemic stroke16
A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis16
The NEK family of serine/threonine kinases as a biomarker for cancer15
A prediction model of sepsis-associated acute kidney injury based on antithrombin III14
Plasma PCSK9 levels and sepsis severity: an early assessment in the emergency department14
Intra-tumor metabolic heterogeneity of gastric cancer on 18F-FDG PETCT indicates patient survival outcomes12
Thyroid peroxidase in human endometrium and placenta: a potential target for anti-TPO antibodies12
DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner12
Vascular endothelial growth factors and angiopoietins as new players in mastocytosis12
Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study12
0.021039009094238